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Bilateral lung masses: The same aetiology?
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Resumo
Os autores descrevem o caso de uma mulher de 50 anos,
fumadora. Assintomática até Setembro de 2003, altura em
que refere o aparecimento de tosse seca, cansaço e perda
de peso. Na radiografia do tórax eram evidentes duas mas-
sas, uma no lobo superior direito e outra no lobo  lingular.
A doente foi submetida a biópsia aspirativa transtorácica
e a citologia obtida foi compatível com carcinoma de
pulmão do tipo pequenas células. No estadiamento da
doença foram identificadas lesões hepáticas secundárias,
motivo porque  a doença foi considerada como dissemi-
nada, dada a existência de lesões hepáticas e pulmonares
contra-laterais. Foi, nesta fase, iniciada quimioterapia com
carboplatinum e etoposídeo. Seis meses mais tarde, a lesão
direita inha diminuído, mas a lesão esquerda apresentava
aumento das suas dimensões. A biópsia desta lesão mos-
trou uma citologia compatível com adenocarcinoma do
Caso Clínico
Clinical Case
Abstract
The authors describe the case of  a 50 year old wom-
an, smoker, healthy until September 2003 when she
presented persistent dry cough, fatigue and weight loss.
Chest x-ray showed two lung masses, one in the supe-
rior right lobe and the other in the lingula lobe of the
left lung.
The patient underwent TFNA (transthoracic fine
needle aspiration) and the cytological result was
compatible with small cell lung cancer. Staging pro-
cedures identified hepatic lesions, probably second-
ary. Presence of  hepatic metastasis and contralat-
eral lung lesions defined the stage of  the disease as
disseminate. Chemotherapy with carboplatin and
etoposide was started. Six months later the right
lesion had decreased but the left lesion had in-
creased. TFNA of  this lesion revealed adenocarci-
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pulmão, motivo porque inicia novo ciclo de quimiotera-
pia com vinorelbina e gencitabina. Aos quatro ciclos e
por não se evidenciar nenhuma resposta ao tratamento,
foi realizada radioterapia da lesão esquerda. Durante este
período (28 meses) mantém-se assintomática, manten-
do a sua actividade diária habitual.
De acordo com o momento do diagnóstico as neo-
plasias do pulmão podem ser consideradas síncronas
ou metácronas. Estas últimas são mais frequentes, re-
presentando cerca de 50-70% dos casos, sendo o pa-
drão histológico mais frequente o adenocarcinoma.
No caso apresentado, a situação parecia ser uma doen-
ça disseminada, o que afastou a hipótese de tumores
síncronos. Apesar de a doença se apresentar num estádio
avançado aquando do diagnóstico e do mau prognósti-
co associado, a evolução dos dois tipos de tumor não
pareceu comprometer a actividade diária da doente.
Rev Port Pneumol 2007; XIII (2): 287-291
Palavras-chave: Tumor primitivo do pulmão, tumores
síncronos do pulmão, tumores metácronos do pulmão.
noma. A new treatment was started with vinorel-
bine and gemcitabine. After four cycles of  chemothe-
rapy without any response patient underwent radio-
therapy of the left lesion.
After 28 months of  follow up the patient was asymp-
tomatic and able to manage her normal daily routine.
Multiple lung cancers can be considered as synchro-
nous or metachronous, depending on the time of  di-
agnosis. Metachronous lesions are the most frequent
(50-70% of all cases) and adenocarcinoma the more
frequent histological pattern.
In this case the disease was at a disseminate stage,
which did not suggest a synchronous lung tumour.
While the disease was at an advanced stage with poor
prognosis at diagnosis, the evolution of  the two dif-
ferent lung tumours did not seem to compromise pa-
tient’s daily routine.
Rev Port Pneumol 2007; XIII (2): 287-291
Key-words: Primitive lung tumor, synchronous lung
tumor, metachronous lung tumour.
Case report
The authors describe the case of  a 50 year
old Caucasian woman, smoker (20 packs-
year), healthy until September 2003 when she
presented with persistent dry cough, lost of
appetite and weight (which she could not
quantify).
In the initial evaluation she presented a nor-
mal physical exam. Chest x-ray was per-
formed and showed two bilateral lung mass-
es, one in the superior right lobe and the
other in the inferior half  of  the left lung (Figs.
1 and 2).
A flexible broncoscopy was performed with
a normal result and there were no malignant
cells in the bronchial lavage.
Diagnosis was obtained by TFNA (trans-
thoracic fine needle aspiration) of the right
lesion. The cytology of  this lesion was com-
patible with small cell lung cancer. The dis-
ease was considered to be in the dissemi-
nate stage due to the existence of  hepatic
lesions (revealed by abdominal ultrasound)
and the presence of a contra-lateral lung
lesion. We started chemotherapy with car-
boplatin (300 mg/m2) and etoposide (120
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mg/m2) every four weeks with a total of
six treatments. Six months after beginning
treatment, radiological evaluation revealed
a reduction of  the right lesion (Fig. 3) and
the disappearance of  the hepatic lesions. An
enlargement of  the left lesion was also seen
(Figs. 3 and 4), with a total absence of  re-
sponse to treatment.
We decided to perform a further TFNA of
the left lingula lobe lesion. The cytology of
this lesion was compatible with adenocar-
cinoma. New chemotherapy treatment with
vinorelbine (30 mg/m2) and gemcitabine
(1250 mg/m2) every three weeks was initi-
ated. After four treatments the lesion was
Figs. 1 and 2 (11-2003) – First radiological evaluation, at
admission
Fig. 3 (04-2004) – Radiological re-evaluation showing
significant reduction of the right lesion
Fig. 4 (06-2004) – Radiological re-evaluation showing
significant enlargement of the left lesion
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unchanged and we decided to initiate radi-
otherapy of  the left lesion. When this treat-
ment was finished an enlargement of  the
right lesion (small cell type) was seen, and
the decision was taken to irradiate this le-
sion (Figs. 5 and 6).  Patient remained
asymptomatic throughout (almost 28
months) with good performance status and
maintenance of daily routine
Discussion
Primitive multiple lung neoplasms are ma-
lignant lesions that are histologically distinct
or, if  they have the same histology, are an-
atomically distinct with no metastatic lesions
and a difference in the DNA sequence1.
These lesions can be divided into synchro-
nous and methacronous neoplasms, de-
pending on the time of  diagnosis. If  the
diagnosis of  two or more neoplasms, his-
tologically different or with the same his-
tology but with different locations in the
lung, is simultaneous with the absence of
metastasis (at a distance or in lymph nodes),
the tumours are synchronous. If  the diag-
noses are made over time (usually 2 years
apart) the neoplasms are metachronous2,3.
This second type of  lesion is the most fre-
quent in primitive multiple lung tumors
(50%-70% of all the cases described)4 with
adenocarcinoma the more frequent histo-
logic type at early or later stages (first or
subsequent lesion)5.
In our case the disease was in an advanced
stage and there was no suspicion of  a syn-
chronous lung neoplasm. Despite the dis-
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Fig. 5 (11-2005) – This image shows the left lesion changes
after treatment of the adenocarcinoma with radiotherapy
Fig. 6 (11-2005) – The left lesion changes after treatment of the adenocarcinoma with areas of radiotherapy-associated
pneumonitis
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seminate stage of  the disease and the prog-
nosis, the evolution of  the two neoplasms
did not determine a deterioration of  the pa-
tient’s general condition.
The cases described in the literature referred
to situations in which the neoplasms were in
an initial stage. The available data on stag-
ing, treatment and prognosis are related to
metachronous lesions which were identified
in a period of  2-5 years after surgery6. Ini-
tially a disseminated form of  small cell lung
cancer was suspected. Conversely, the delay
in the diagnosis of the adenocarcinoma did
not impact on the evolution of  the disease.
Surgery was not considered at diagnosis of
the adenocarcinoma (left lesion); we consid-
ered that surgery did not improve patient
survival and quality of  life in the face of  con-
comitant generalised small cell lung cancer
and so opted for chemotherapy.
Another possible strategy was palliative ra-
diotherapy; this decision was taken in order
to halt tumour growth in the absence of  re-
sponse after two chemotherapy courses.
This case raises some questions in diagnosis
and treatment which still remain to be answered.
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